Tag: retinitis pigmentosa
Five Questions With: Pam Stetkiewicz
After operating in stealth for its first year, Lyora Therapeutics publicly launched in July, announcing Pam Stetkiewicz as the Providence-based biotech company’s CEO.
With $2.5 million in pre-seed funding, Lyora develops medications for those living with inherited...
- Featured Event -
